Using a Nobel Prize-winning technique called cryo-EM, researchers were able to identify potential areas on the hepatitis C virus that a vaccine could target.
Academic rigor, journalistic flair
Articles on Hepatitis vaccine
Displaying all articles
The 2020 Nobel Prize for Physiology or Medicine goes to the discoverers of the hepatitis C virus. There’s an effective cure but homelessness and the opioid epidemic are driving a surge in infections.
HIV/AIDS receives more funding than hepatitis, which is responsible for more deaths.
About 19 million Nigerians have hepatitis but most of them don’t know it.
Hepatitis B rates in Indigenous communities are ten times higher than the rest of Australia. Eliminating the infection from Indigenous Australia can make a significant contribution to closing the gap.
Ghana must urgently implement strategies to tackle the high burden of viral hepatitis if it’s to fulfill global targets of eliminating the disease by 2030.
Top contributors
-
Director, WHO Collaborating Centre for Viral Hepatitis, The Peter Doherty Institute for Infection and Immunity
-
Director of POCHE Centre for Indigenous Health, The University of Queensland
-
Research Fellow at Monash University, Monash University
-
Associate Professor, The Peter Doherty Institute for Infection and Immunity
-
Professor of Internal Medicine, University of Michigan
-
Associate Research Scientist, African Population and Health Research Center
-
Lecturer, Gastroenterology & Hepatology Unit and Consultant Gastroenterologist & Hepatologist , University of Ibadan
-
Obstetrician and Gynecologist, Mbarara University of Science and Technology
-
Postdoctoral Fellow in Integrative Structural and Computational Biology, The Scripps Research Institute
-
Postdoctoral Scholar in Molecular and Cell Biology, The Scripps Research Institute
